Cancer Vaccine
Peptide motifs for nonviral gene delivery selective for dividing cells have been explored
Published in Vaccine Weekly, March 15th, 2006
According to a study from England, "The immunogenicity of viral DNA vectors is an important problem for gene therapy. The use of peptide motifs for gene delivery would largely overcome this problem, and provide a simple, safe and powerful approach for non-viral gene therapy. We explored the functional properties of two motifs: the (Lys)16 motif (for binding and condensing DNA and probably also nuclear, translocation of plasmids) and the fusogenic peptide motif of influenza virus (for acid-dependent...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-03-15)
More Articles from Vaccine Weekly
- Coccidioidomycosis Vaccine
Aspartyl protease protects against pulmonary coccidioidomycosis - Escherichia Coli Vaccine
Attenuated enterotoxigenic Escherichia coli vaccine is immunogenic and safe - Tuberculosis Vaccine
BCG vaccination poses risk of BCG-induced disease in HIV-infected children - Tuberculosis Vaccine
Tuberculosis DNA vaccine efficacy is enhanced by plasmid IL-23 - Vaccine Adjuvant
Bacterial flagellin possesses strong mucosal adjuvant activity - Adenovirus Vaccine
Adenoviral infection is prevented by group V and X secretory phospholipase A2 - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
